GLP-1 treatment guide
Eligibility framing
A provider decides whether GLP-1 therapy is appropriate after reviewing your health history, medications, and goals. People with certain conditions may not be candidates. In particular, these medicines are not for use if you or a family member have a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Your provider will also consider pancreatitis history, gallbladder disease, kidney problems, diabetic eye disease, pregnancy or breastfeeding plans, and other factors.
Completing a questionnaire does not guarantee approval or a prescription.
Treatment process
- Start an online visit and share accurate medical information.
- A U.S.-licensed provider reviews your case.
- If your state requires it, complete a synchronous real-time audio or video visit before a prescription is issued.
- If prescribed, a licensed pharmacy partner dispenses and ships your medication.
- Follow your provider’s dosing and follow-up plan; message the care team with questions.
See also: online GLP-1 weight loss care and how AVArx works.
Side effects overview
Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. Serious risks can include pancreatitis, gallbladder problems, low blood sugar (especially with certain diabetes medicines), kidney injury related to dehydration, serious allergic reactions, and vision changes. GLP-1 medicines also carry a boxed warning regarding thyroid C-cell tumors observed in rodents.
Read the full Important Safety Information on each treatment page before starting a visit:
Public safety resources: FDA Drugs.
Costs and payment
AVArx does not bill insurance directly. You can review the applicable plan total before checkout. HSA/FSA payment may be available, and receipts can be provided for reimbursement. Exact pricing depends on the treatment and plan selected during your visit — confirm totals in the intake flow before paying.